Chauhan, Shefali
Lian, Emily
Habib, Iman
Liu, Qianqian
Anders, Nicole M.
Bugg, Megan M.
Federman, Noah C.
Reid, Joel M.
Stewart, Clinton F.
Cates, Tristan
Michalek, Joel E.
Keller, Charles
Article History
Received: 26 March 2024
Accepted: 2 July 2024
First Online: 15 August 2024
Competing interests
: CK has sponsored research agreements or collaborations with Roche-Genentech, Nurix Therapeutics and Novartis and is co-founder of Tio Companies and Teo Therapeutics. Artisan Biopharma is a wholly owned subsidiary of cc-TDI. CK previously received a $75,000 unrestricted research grant from Syndax Pharmaceuticals. Dr. Peter Ordentlich of Syndax Pharmaceuticals is a scientific advisory board member of cc-TDI. The other authors have no conflicts of interest to declare.